REFERENCES
- Kang J, Levinson JA, Hitti IF. Leiomyosarcoma of the parotid gland: a case report and review of the literature. Head Neck 21 (1999), 168–171.
- Luna MA, Tortoledo E, Ordonez G, Frankenthaler RA, Bat-sakis JG. Primary sarcomas of the salivary glands. Arch Oto-laryngol 1991; 117: 320–306.
- Auclair PL, Langloss JM, Weiss SW, Corio RL. Sarcoma and sarcomatoid neoplasms of the major salivary gland regions. Cancer 1986; 58: 1305–1315.
- Joshi W, Gagnon GA, Chadwick EG et al. The spectrum of mucosa- associated lymphoid tissue lesions in pediatric Patients infected with HIV: a clinicopathologic study of six cases. Am J Clin Pathol 1997; 107 (5): 592–600
- Ando M, Matsuzaki M, Murofushi T. Mucosa-associated tissue lymphoma presented as diffuse swelling of the parotid gland. Am J Otolaryng 2005; 26: 285–88
- Boulanger E, meignin V, Baia M et al. Mucosa associated lymphoid tissue lymphoma in patients with human immunodefi-ciency virus infection. Br J Haem 2007, 140: 464–74
- Carbone A, Gloghini A, Ferlito A. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type. Ann Otol Rhinol Laryngol 2000, 109 (12 Pt 1): 1170–5
- Ellis GL. Lymphoid lesions of salivary glands: malignant and benign. Med Oral Patol Oral Cir Bucal 2007; 12 (7): E479–85
- Suankratay C, Shuangshoti S, Mutirangura A et al. Epstein-Barr virus infection-associated smooth-muscle tumors in patients with AIDS. CID 2005; 40: 1521–1528
- Deyrup AT, Lee VK, Hill CE et al. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tu-mors reflecting multiple infection events. A clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 2006; 30 (1): 75–82
- Jenson HB, Montalvo EA, McClain KL et al. Characteri-zation of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. J Med Virol 1999; 57: 36–46
- Liebowitz D. Epstein-Barr virus - An old dog with new tricks. N Engl J Med 1995; 332: 55–67
- Hill MA, Araya JC, Eckert MW et al. Tumor specific Ep-stein-Barr Virus infection is not associated with leiomyosarcoma in Human Immunodeficiency Virus negative individuals. Cancer 1997; 80 (2): 204–210
- Ashawani S, Sumit M, Deepika S, Mandal AK, Agarwal AK. Parotid gland leiomyosarcoma in a child: An extremely un-usual neoplasm. Oral Surg., Oral med., Oral Path., Oral Rad., and endocrinol; 2006; 102 (1): 82–84.
- Zbaren P, Ruchti C. Leiomyosarcoma of the middle ear and temporal bone. Ann Otol Rhinol Laryngol. 1994; 103: 537–541.
- Kruger S, Sommer K Leiomyosarcoma of the parotid gland: a case report. Eur Arch Otorhinolaryngol 2006; 263: 951–954
- Parker SL, Tong T, Golden S, Wingo PA. Cancer statis-tics, 1996. CA Cancer J Clin 1996; 46: 5–27
- Gaynor JJ, Tan CC, Casper ES, et al. Refinement of din-ico-pathologic staging for localized soft tissue sarcoma of the ex-tremety: a study of 423 adults. J Clin Oncol 1992; 10: 1317-1329
- Broders AC, Hargrave R, Meyerding HW et al. Patholog-ical features of soft tissue fibrosarcoma with special reference to the grading of its malignancy. Surg Gynecol Obstet 1939; 69: 267–272
- Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft tissue sarcomas of the extremities : prospective random-ized evaluations of 1) limb-sparing surgery plus radiaton therapy compared with amputation and 2) the role of adjuvant chemotherapy. Ann Surg 1982; 196: 305–15.
- Benjamin R, Wiernik PH, Bachur NR. Adryamicin: a new effective agent in the therapy of disseminated sarcomas. Med Pe-diatr Oncol 1975; 1: 63–76
- Antman KH, Ryan L, Elias A, et al. Response to ifos-famide and mesna, in previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 1989; 7: 126–31.
- Maki GR, Wathen JK, Patel SR et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas. J Clin Oncol 2007; 25: 2755–2763.
- Herida M, Mary-Krause M, Kaplan R et al. Incidence of non-AIDS-defining cancers before and during the highly active anti-retroviral therapy in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 15: 21 (18): 3447-53.